Sage Therapeutics Inc (SAGE)
13.94
+0.84
(+6.37%)
USD |
NASDAQ |
May 03, 16:00
13.95
+0.01
(+0.07%)
After-Hours: 20:00
Sage Therapeutics Market Cap: 838.94M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 838.94M |
| May 02, 2024 | 788.69M |
| May 01, 2024 | 799.22M |
| April 30, 2024 | 838.94M |
| April 29, 2024 | 853.38M |
| April 26, 2024 | 823.89M |
| April 25, 2024 | 817.27M |
| April 24, 2024 | 842.55M |
| April 23, 2024 | 779.36M |
| April 22, 2024 | 775.75M |
| April 19, 2024 | 802.23M |
| April 18, 2024 | 784.47M |
| April 17, 2024 | 756.49M |
| April 16, 2024 | 940.64M |
| April 15, 2024 | 921.99M |
| April 12, 2024 | 929.21M |
| April 11, 2024 | 997.22M |
| April 10, 2024 | 989.99M |
| April 09, 2024 | 994.21M |
| April 08, 2024 | 999.02M |
| April 05, 2024 | 988.19M |
| April 04, 2024 | 997.82M |
| April 03, 2024 | 1.032B |
| April 02, 2024 | 1.038B |
| April 01, 2024 | 1.077B |
| Date | Value |
|---|---|
| March 28, 2024 | 1.126B |
| March 27, 2024 | 1.144B |
| March 26, 2024 | 1.119B |
| March 25, 2024 | 1.123B |
| March 22, 2024 | 1.155B |
| March 21, 2024 | 1.200B |
| March 20, 2024 | 1.183B |
| March 19, 2024 | 1.159B |
| March 18, 2024 | 1.164B |
| March 15, 2024 | 1.200B |
| March 14, 2024 | 1.191B |
| March 13, 2024 | 1.239B |
| March 12, 2024 | 1.223B |
| March 11, 2024 | 1.273B |
| March 08, 2024 | 1.328B |
| March 07, 2024 | 1.284B |
| March 06, 2024 | 1.270B |
| March 05, 2024 | 1.276B |
| March 04, 2024 | 1.309B |
| March 01, 2024 | 1.314B |
| February 29, 2024 | 1.291B |
| February 28, 2024 | 1.355B |
| February 27, 2024 | 1.365B |
| February 26, 2024 | 1.360B |
| February 23, 2024 | 1.323B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
756.49M
Minimum
Apr 17 2024
9.777B
Maximum
Jul 12 2019
3.251B
Average
2.548B
Median
Dec 30 2021
Market Cap Benchmarks
| Biogen Inc | 31.67B |
| Perspective Therapeutics Inc | 1.062B |
| Vanda Pharmaceuticals Inc | 280.78M |
| Ligand Pharmaceuticals Inc | 1.308B |
| ADMA Biologics Inc | 1.554B |
Market Cap Related Metrics
| PS Ratio | 9.177 |
| Price to Book Value | 1.189 |
| Price | 13.94 |
| Earnings Yield | -60.19% |